CDTX Financial Statements

Balance sheet, income statement, cash flow, and dividends for Cidara Therapeutics Inc (CDTX).


$189.41M Market Cap.

As of 03/06/2025 5:00 PM ET (MRY) • Disclaimer

CDTX Market Cap. (MRY)


CDTX Shares Outstanding (MRY)


CDTX Assets (MRY)


Total Assets

$214.80M

Total Liabilities

$51.49M

Total Investments

$0

CDTX Income (MRY)


Revenue

$1.27M

Net Income

-$169.83M

Operating Expense

$177.38M

CDTX Cash Flow (MRY)


CF Operations

-$176.53M

CF Investing

-$129.00K

CF Financing

$337.06M

CDTX Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

CDTX Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$214,796,000 (220.45%)

$67,030,000 (40.84%)

$47,593,000 (-36.82%)

$75,325,000 (24.66%)

Assets Current

$210,737,000 (246.29%)

$60,855,000 (34.95%)

$45,094,000 (-37.11%)

$71,698,000 (25.37%)

Assets Non-Current

$4,059,000 (-34.27%)

$6,175,000 (147.10%)

$2,499,000 (-31.10%)

$3,627,000 (12.19%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$163,308,000 (2089.14%)

-$8,210,000 (-182.71%)

-$2,904,000 (-113.46%)

$21,573,000 (101.33%)

Property Plant & Equipment Net

$3,963,000 (-22.70%)

$5,127,000 (259.29%)

$1,427,000 (-43.89%)

$2,543,000 (110.17%)

Cash & Equivalents

$196,177,000 (448.32%)

$35,778,000 (9.31%)

$32,731,000 (-47.44%)

$62,273,000 (44.99%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$29,340,000 (-16.50%)

$35,139,000 (8.68%)

$32,333,000 (29.28%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$6,097,000 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$1,694,000 (-89.57%)

$16,246,000 (178.52%)

$5,833,000 (8.91%)

$5,356,000 (-52.07%)

Trade & Non-Trade Payables

$3,608,000 (-4.35%)

$3,772,000 (160.68%)

$1,447,000 (11.22%)

$1,301,000 (-71.52%)

Accumulated Retained Earnings (Deficit)

-$611,258,000 (-38.47%)

-$441,431,000 (-8.47%)

-$406,966,000 (-7.90%)

-$377,167,000 (-12.69%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$26,045,000 (44.37%)

$18,040,000 (0%)

$0 (0%)

$0 (0%)

Total Debt

$3,576,000 (-26.68%)

$4,877,000 (270.31%)

$1,317,000 (-73.98%)

$5,061,000 (-36.44%)

Debt Current

$1,642,000 (26.31%)

$1,300,000 (-1.29%)

$1,317,000 (-64.78%)

$3,739,000 (-53.04%)

Debt Non-Current

$1,934,000 (-45.93%)

$3,577,000 (0%)

$0 (0%)

$1,322,000 (0%)

Total Liabilities

$51,488,000 (-31.57%)

$75,240,000 (49.00%)

$50,497,000 (-6.06%)

$53,752,000 (8.13%)

Liabilities Current

$49,554,000 (-26.50%)

$67,418,000 (124.94%)

$29,972,000 (-11.89%)

$34,017,000 (-11.79%)

Liabilities Non-Current

$1,934,000 (-75.27%)

$7,822,000 (-61.89%)

$20,525,000 (4.00%)

$19,735,000 (77.07%)

CDTX Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$1,275,000 (-98.00%)

$63,905,000 (-0.60%)

$64,288,000 (29.69%)

$49,572,000 (310.81%)

Cost of Revenue

$0 (0%)

$1,523,000 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$20,615,000 (12.45%)

$18,333,000 (-0.83%)

$18,486,000 (-1.36%)

$18,740,000 (17.87%)

Research & Development Expense

$71,879,000 (4.88%)

$68,532,000 (-9.25%)

$75,520,000 (3.33%)

$73,087,000 (7.45%)

Operating Expenses

$177,377,000 (104.20%)

$86,865,000 (-7.60%)

$94,006,000 (2.37%)

$91,827,000 (9.43%)

Interest Expense

$0 (0%)

$0 (0%)

-$191,000 (-190.09%)

$212,000 (-19.08%)

Income Tax Expense

$0 (0%)

$443,000 (62.87%)

$272,000 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

-$464,000 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$169,827,000 (-640.60%)

-$22,931,000 (23.05%)

-$29,799,000 (29.83%)

-$42,467,000 (41.11%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$169,827,000 (-640.60%)

-$22,931,000 (23.05%)

-$29,799,000 (29.83%)

-$42,467,000 (41.11%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$169,827,000 (-640.60%)

-$22,931,000 (23.05%)

-$29,799,000 (29.83%)

-$42,467,000 (43.28%)

Weighted Average Shares

$6,349,631 (-92.74%)

$87,427,439 (25.15%)

$69,857,698 (33.18%)

$52,453,452 (26.22%)

Weighted Average Shares Diluted

$6,349,631 (-92.74%)

$87,427,439 (25.15%)

$69,857,698 (33.18%)

$52,453,452 (26.22%)

Earning Before Interest & Taxes (EBIT)

-$169,827,000 (-655.19%)

-$22,488,000 (24.33%)

-$29,718,000 (29.67%)

-$42,255,000 (41.19%)

Gross Profit

$1,275,000 (-97.96%)

$62,382,000 (-2.96%)

$64,288,000 (29.69%)

$49,572,000 (310.81%)

Operating Income

-$176,102,000 (-619.28%)

-$24,483,000 (17.62%)

-$29,718,000 (29.67%)

-$42,255,000 (41.19%)

CDTX Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$129,000 (74.46%)

-$505,000 (-327.97%)

-$118,000 (-187.80%)

-$41,000 (77.96%)

Net Cash Flow from Financing

$337,061,000 (1197.19%)

$25,984,000 (2832.28%)

-$951,000 (-102.13%)

$44,597,000 (19.63%)

Net Cash Flow from Operations

-$176,533,000 (-686.97%)

-$22,432,000 (21.22%)

-$28,473,000 (-12.84%)

-$25,232,000 (53.63%)

Net Cash Flow / Change in Cash & Cash Equivalents

$160,399,000 (5164.16%)

$3,047,000 (110.31%)

-$29,542,000 (-252.88%)

$19,324,000 (211.58%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$129,000 (74.46%)

-$505,000 (-327.97%)

-$118,000 (-187.80%)

-$41,000 (77.96%)

Issuance (Repayment) of Debt Securities

-$276,000 (0%)

$0 (0%)

-$2,593,000 (41.65%)

-$4,444,000 (-49.98%)

Issuance (Purchase) of Equity Shares

$337,376,000 (1198.40%)

$25,984,000 (1482.46%)

$1,642,000 (-96.65%)

$49,041,000 (21.87%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$3,907,000 (27.64%)

$3,061,000 (-13.34%)

$3,532,000 (-12.01%)

$4,014,000 (-1.86%)

Depreciation Amortization & Accretion

$1,281,000 (0.39%)

$1,276,000 (792.31%)

$143,000 (-24.34%)

$189,000 (-33.92%)

CDTX Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (2.46%)

97.60% (-2.40%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-13319.80% (-37002.51%)

-35.90% (22.63%)

-46.40% (45.86%)

-85.70% (86.19%)

EBITDA Margin

-13219.30% (-39717.17%)

-33.20% (27.83%)

-46.00% (45.82%)

-84.90% (85.68%)

Return on Average Equity (ROAE)

-173.30% (20.50%)

-218.00% (94.22%)

-3773.20% (-746.20%)

-445.90% (-101.58%)

Return on Average Assets (ROAA)

-112.60% (-244.34%)

-32.70% (42.63%)

-57.00% (17.99%)

-69.50% (34.68%)

Return on Sales (ROS)

-13319.80% (-37740.34%)

-35.20% (23.81%)

-46.20% (45.77%)

-85.20% (85.69%)

Return on Invested Capital (ROIC)

705.80% (354.77%)

155.20% (-25.31%)

207.80% (-4.11%)

216.70% (-64.05%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1 (67.09%)

-3.05 (-73.62%)

-1.76 (-12.18%)

-1.57 (-41.13%)

Price to Sales Ratio (P/S)

133.87 (12226.43%)

1.09 (32.12%)

0.82 (-38.84%)

1.34 (-80.49%)

Price to Book Ratio (P/B)

1.16 (113.26%)

-8.75 (53.11%)

-18.65 (-575.09%)

3.93 (-52.13%)

Debt to Equity Ratio (D/E)

0.32 (103.44%)

-9.16 (47.30%)

-17.39 (-797.79%)

2.49 (-46.28%)

Earnings Per Share (EPS)

-26.75 (-10188.46%)

-0.26 (39.53%)

-0.43 (46.91%)

-0.81 (55.00%)

Sales Per Share (SPS)

0.2 (-72.50%)

0.73 (-20.54%)

0.92 (-2.65%)

0.94 (225.86%)

Free Cash Flow Per Share (FCFPS)

-27.82 (-10519.08%)

-0.26 (35.94%)

-0.41 (15.15%)

-0.48 (63.32%)

Book Value Per Share (BVPS)

25.72 (27460.64%)

-0.09 (-123.81%)

-0.04 (-110.22%)

0.41 (59.30%)

Tangible Assets Book Value Per Share (TABVPS)

33.83 (4310.43%)

0.77 (12.63%)

0.68 (-52.58%)

1.44 (-1.24%)

Enterprise Value Over EBIT (EV/EBIT)

0 (0%)

-1 (0%)

0 (0%)

-1 (0.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.39 (69.83%)

-1.3 (-1308.70%)

-0.09 (92.37%)

-1.21 (-98.36%)

Asset Turnover

0.01 (-99.12%)

0.91 (-25.79%)

1.23 (51.54%)

0.81 (374.27%)

Current Ratio

4.25 (370.99%)

0.9 (-40.00%)

1.5 (-28.61%)

2.11 (42.14%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$176,662,000 (-670.21%)

-$22,937,000 (19.78%)

-$28,591,000 (-13.13%)

-$25,273,000 (53.71%)

Enterprise Value (EV)

$65,970,495 (139.97%)

$27,491,419 (915.28%)

$2,707,762 (-94.66%)

$50,735,289 (16.65%)

Earnings Before Tax (EBT)

-$169,827,000 (-655.19%)

-$22,488,000 (23.84%)

-$29,527,000 (30.47%)

-$42,467,000 (41.11%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$168,546,000 (-694.58%)

-$21,212,000 (28.28%)

-$29,575,000 (29.69%)

-$42,066,000 (41.22%)

Invested Capital

-$27,359,000 (12.56%)

-$31,289,000 (-126.85%)

-$13,793,000 (13.27%)

-$15,904,000 (-21.15%)

Working Capital

$161,183,000 (2555.93%)

-$6,563,000 (-143.40%)

$15,122,000 (-59.87%)

$37,681,000 (102.29%)

Tangible Asset Value

$214,796,000 (220.45%)

$67,030,000 (40.84%)

$47,593,000 (-36.82%)

$75,325,000 (24.66%)

Market Capitalization

$189,413,495 (163.79%)

$71,804,419 (32.57%)

$54,164,762 (-36.04%)

$84,691,289 (-3.62%)

Average Equity

$98,023,500 (831.80%)

$10,519,750 (1232.04%)

$789,750 (-91.71%)

$9,524,000 (-71.86%)

Average Assets

$150,800,000 (115.26%)

$70,055,000 (33.90%)

$52,317,500 (-14.40%)

$61,121,250 (-13.18%)

Invested Capital Average

-$24,061,250 (-66.01%)

-$14,494,250 (-1.35%)

-$14,300,500 (26.67%)

-$19,501,750 (-63.60%)

Shares

7,046,633 (-92.21%)

90,433,777 (26.27%)

71,618,091 (7.40%)

66,686,054 (51.77%)